A Clinical Appraisal of Calcitonin

Aliapoulios M. A. Voelkel E. F. Munson P. L. (1966). Assay of human thyroid glands for thyrocalcitonin activity. Journal of Clinical Endocrinology, 26, 897

Bijvoet O. L. M. Veer J. V. D. Stays Wildiers J. Smeenk D. (1969). Effects of prolonged administration of thyrocalcitonin in human senile osteoporosis. In Calcitonin: Proceedings of the second international symposium, p. 531, Edited by Taylor S . London: Heineman

Boyle I. T. Greig W. R. McDonald E. Brown J. (1970). Unpublished data

Caniggia A. Gennari C. Bencini M. Cesari L. Borrello G. (1970). Calcium metabolism and ⁴⁷Calcium kinetics before and after long term thyrocalcitonin treatment in senile osteoporosis. Clinical Science, 38, 397

Cochran M. Peacock M. Sachs G. Nordin B. E. C. (1969). Renal effects of calcitonin. In Calcitonin: Proceedings of the second international symposium, p. 523, Edited by Taylor S . London: Heinemann

Copp D. H. Cameron E. C. Cheney B. A. Davidson A. G. F. Henze K. G. (1962). Evidence for calcitonin—a new hormone from the parathyroid that lowers blood calcium. Endocrinology, 70, 638

Cunliffe W. J. Black M. M. Hall R. Johnston I. D. A. Hodgson P. Sinister S. Gudmundsson T. V. Joplin G. F. Williams E. D. Woodhouse N. J. Y. Galante L. MacIntyre I. (1968). A calcitonin-secreting thyroid carcinoma. Lancet, 1, 63

Foster G. V. Joplin G. F. MacIntyre I. Melvin K. E. W. Slack E. (1966). Effect of thyrocalcitonin in man. Lancet, 1, 107

Galante L. Gudmundsson T. V. Matthews E. W. Tse A. Williams E. D. Woodhouse N. J. Y. MacIntyre I. (1968). Thymic and parathyroid origin of calcitonin in man. Lancet, 11, 537

Gudmundsson T. V. Galante L. Horton R. Matthews E. W. Woodhouse N. J. Y. MacIntyre I. (1969). Human plasma calcitonin. In Calcitonin: Proceedings of the second international symposium, p. 102, Edited by Taylor S . London: Heinemann

Hioco D. Bordier Ph. Miravet L. Denys H. Tun-Chot S. (1969). Prolonged administration of calcitonin in man: Biological, isotopic and morphological effects. In Calcitonin: Proceedings of the second international symposium, p. 514, Edited by Taylor S . London: Heinemann

Martin T. J. Robinson C. J. MacIntyre I. (1966). The mode of action of thyrocalcitonin. Lancet, 1, 900

Merz W. A. Schenk R. K. Reutter F. W. (1970). Paradoxical effects of Vitamin D in fluoride treated senile osteoporosis. Calcitonin Tissue Research, 4, (supplement), 49

Murphy H. M. (1970). Osteopetrosis in the mouse. A possible case of acute hyperthyro-calcitoninism. Calcitonin Tissue Research, 4, (supplement), 152

Pak C. Y. C. Ruskin B. Casper A. (1969). Renal effects of thyrocalcitonin. In Calcitonin: Proceedings of the second international symposium, p. 154, Edited by Taylor S . London: Heinemann

Pearse A. G. E. Carvalheira A. F. (1967). Cytochemical evidence for an ultimobranchial origin of rodent thyroid ‘C’ cells. Nature, 214, 929

Veer J. V. D. Sluys Bijvoet O. C. M. Smeenk D. (1970). Effects of long-term porcine calcitonin administration in patients with Paget's disease or osteoporosis. Calcitonin Tissue Research, 4, (supplement), 88

Smith R. N. Laljee H. C. K. (1967). Thyrocalcitonin deficiency in man. In Thyrotoxicosis, p. 186, Edited by Irvine W. J. , Edinburgh: Livingstone

Solda E. Capella C. Sampietro R. Vassallo G. (1969). The distribution of human C cells and their relationship to osteopetrosis and medullary carcinoma of the thyroid. In Calcitonin: Proceedings of the second international symposium, Edited by Taylor S . London: Heinemann

Williams E. D. Kavim S. M. M. Sandler M. (1968). Prostaglandin secretion by medullary carcinoma of the thyroid. A possible cause of the associated diarrhoea. Lancet, 1, 22